Search

everythinglearnresearchcommunity

for

Search:↓

Gene differences affect finasteride side effects in men with hair loss.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Topical 4-aminopyridine 5% does not improve hair growth in male pattern baldness.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib is effective and safe for treating severe alopecia areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Mutations in the LIPH gene cause woolly hair in a child.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.